SynthesisJournal of human hypertension2019

Empagliflozin reduces blood pressure and uric acid in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Di Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.